DELAET INGRID (Chief Regulatory Officer) sold 8.8% of their position (457.00 shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $61.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/11/2025ACC: 0000914475-25-000153
Officer· Chief Regulatory Officer
Since Feb 2026
-457.00
Net shares
Net seller
$61.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
457.00 acquired · 914.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+457.00
Price / share
$79.02
Trade value
$36.11K
% of position
9.7%
7/10/2025
4.73K→5.19K
Common Stock
Direct
Shares
−457.00
Price / share
$135.00
Trade value
$61.70K
% of position
8.8%
7/10/2025
5.19K→4.73K
Total
Net shares
+0.00
Net value
-$25.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/10/2025 | M · Option Exercise | +457.00 | $79.02 | $36.11K | 9.7% | 4.73K | 5.19K |
| Common Stock Direct | 7/10/2025 | S · Sale | −457.00 | $135.00 | $61.70K | 8.8% | 5.19K | 4.73K |
| Total | +0.00 | -$25.58K | ||||||
Derivative Transactions1
Non-Qualified Stock Option
Direct
Converts to
Common Stock
457.00 shares
Shares
−457.00
Strike price
79.02
Held after
2.26K
Exercisable
—
7/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option Direct | Common Stock457.00 shares | 7/10/2025 | M · Option Exercise | −457.00 | 79.02 | — | 2.26K |